Jie Song

Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial

Antoní Torres, Nanshan Zhong, Jan Pachl et al. · The Lancet Infectious Diseases · 2017 · 443 citations

Medicine, Clinical Sciences, Infectious Diseases +17

A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia

Xinyu Qin, Binh Giang Tran, Min Ja Kim et al. · International Journal of Antimicrobial Agents · 2017 · 132 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +11

Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme

Gregory G. Stone, Paul Newell, Leanne B. Gasink et al. · Journal of Antimicrobial Chemotherapy · 2018 · 77 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Preoperative albumin-to-fibrinogen ratio predicts severe postoperative complications in elderly gastric cancer subjects after radical laparoscopic gastrectomy

Xuexue You, Qun Zhou, Jie Song et al. · BMC Cancer · 2019 · 57 citations · Full text

Medicine, Oncology, Surgery +17

EIF2AK4 mutation as “second hit” in hereditary pulmonary arterial hypertension

Christina A. Eichstaedt, Jie Song, Nicola Benjamin et al. · Respiratory Research · 2016 · 49 citations · Full text

Medicine, Genetics, Molecular Genetics +13